CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
CareDx is looking for a SOX intern professional to be part of the team that oversees internal control over financial reporting (“ICFR”). This is an exciting and educational opportunity to assist with evaluating the Company’s SOX program and partner with functions across the company to ensure a strong environment for ICFR. This position reports to the Senior Manager, SOX Compliance, and is based in Brisbane, California.
This is a long-term internship through the end of 2026, offering full-time hours during the summer (May–August) and flexible part-time hours for the remainder of the year.
Responsibilities:
- Document controls, processes and procedures related to SOX 404 compliance.
- Update internal control documentation and assist internal and external auditors with controls walk-throughs.
- Perform SOX testing for internal business process and IT controls.
- Assist in ad hoc/special projects, as needed.
Qualifications:
- Pursuing a Bachelor's Degree or Masters Degree in Accounting, Finance, Economics, MIS or related area.
- A robust analytical skill-set. Advanced experience in Excel. Experience with Microsoft with Microsoft Office Suite (Word, Excel, PowerPoint).
- Ability to work independently and within a team environment, detail-oriented, and execution focused.
- Strong verbal, written and presentation skills.
- Highly collaborative and team-oriented.
- Knowledge of accounting principles and financial statements.
- Knowledge of the requirements of Sarbanes-Oxley Act, Section 404, PCAOB standards, and other applicable professional guidance.
CareDx, Inc. is an Equal Opportunity Employer-vets/disabled, and participates in the E-Verify program.
By proceeding with our application and submitting your information, you acknowledge that you have read our U.S. Personnel Privacy Notice and consent to receive email communication from CareDx.
***We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.***
Certain jurisdictions require notice of how we use and protect your personal information. For more information, please read our Privacy Policy
This is the anticipated base salary range for candidates who will work in Brisbane, California. The final salary offered to a successful candidate will be dependent on several factors that may include, but are not limited to, the type and length of experience within the job, the type and length of experience within the industry, education, etc. Base pay is one part of the Total Package that is provided to compensate and recognize employees for their work, and this role may be eligible for additional discretionary bonuses/incentives and restricted stock units. CareDx is a multi-state employer, and this salary range may not reflect positions that work in other states.
Skills Required
- Pursuing a Bachelor's Degree or Master's Degree in Accounting, Finance, Economics, MIS or related area
- Robust analytical skill-set and advanced experience in Excel
- Knowledge of the requirements of Sarbanes-Oxley Act, Section 404
- Strong verbal, written and presentation skills
- Ability to work independently and in a team environment
What We Do
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
.jpeg)
